Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paulina M Wojnarowicz

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
International Journal of Oncology|February 21, 2012
Chromosome 17q25 genes, RHBDF2 and CYGB, in ovarian cancerPaulina M Wojnarowicz, Diane M Provencher, Anne-Marie Mes-Masson, et al.
International Journal of Oncology|January 29, 2013
FKBP10/FKBP65 expression in high-grade ovarian serous carcinoma and its association with patient outcomeMichael C J Quinn, Paulina M Wojnarowicz, Amy Pickett, et al.
Molecular Cancer Therapeutics|August 24, 2017
HPMA-Copolymer Nanocarrier Targets Tumor-Associated Macrophages in Primary and Metastatic Breast CancerMelissa N Zimel, Chloe B Horowitz, Vinagolu K Rajasekhar, et al.
Journal of Translational Medicine|July 8, 2009
The chemiluminescence based Ziplex automated workstation focus array reproduces ovarian cancer Affymetrix GeneChip expression profilesMichael C J Quinn, Daniel J Wilson, Fiona Young, et al.
Molecular Oncology|February 19, 2013
VGLL3 expression is associated with a tumor suppressor phenotype in epithelial ovarian cancerKaren Gambaro, Michael C J Quinn, Paulina M Wojnarowicz, et al.
Plos One|October 3, 2012
The genomic landscape of TP53 and p53 annotated high grade ovarian serous carcinomas from a defined founder population associated with patient outcomePaulina M Wojnarowicz, Kathleen Klein Oros, Michael C J Quinn, et al.
NPJ Breast Cancer|May 25, 2021
Anti-tumor effects of an ID antagonist with no observed acquired resistancePaulina M Wojnarowicz, Marta Garcia Escolano, Yun-Han Huang, et al.
Cell Reports|October 3, 2019
A Small-Molecule Pan-Id Antagonist Inhibits Pathologic Ocular NeovascularizationPaulina M Wojnarowicz, Raquel Lima E Silva, Masayuki Ohnaka, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
International Journal of Oncology|February 21, 2012
Chromosome 17q25 genes, RHBDF2 and CYGB, in ovarian cancerPaulina M Wojnarowicz, Diane M Provencher, Anne-Marie Mes-Masson, et al.
International Journal of Oncology|January 29, 2013
FKBP10/FKBP65 expression in high-grade ovarian serous carcinoma and its association with patient outcomeMichael C J Quinn, Paulina M Wojnarowicz, Amy Pickett, et al.
Molecular Cancer Therapeutics|August 24, 2017
HPMA-Copolymer Nanocarrier Targets Tumor-Associated Macrophages in Primary and Metastatic Breast CancerMelissa N Zimel, Chloe B Horowitz, Vinagolu K Rajasekhar, et al.
Journal of Translational Medicine|July 8, 2009
The chemiluminescence based Ziplex automated workstation focus array reproduces ovarian cancer Affymetrix GeneChip expression profilesMichael C J Quinn, Daniel J Wilson, Fiona Young, et al.
Molecular Oncology|February 19, 2013
VGLL3 expression is associated with a tumor suppressor phenotype in epithelial ovarian cancerKaren Gambaro, Michael C J Quinn, Paulina M Wojnarowicz, et al.
Plos One|October 3, 2012
The genomic landscape of TP53 and p53 annotated high grade ovarian serous carcinomas from a defined founder population associated with patient outcomePaulina M Wojnarowicz, Kathleen Klein Oros, Michael C J Quinn, et al.
NPJ Breast Cancer|May 25, 2021
Anti-tumor effects of an ID antagonist with no observed acquired resistancePaulina M Wojnarowicz, Marta Garcia Escolano, Yun-Han Huang, et al.
Cell Reports|October 3, 2019
A Small-Molecule Pan-Id Antagonist Inhibits Pathologic Ocular NeovascularizationPaulina M Wojnarowicz, Raquel Lima E Silva, Masayuki Ohnaka, et al.
Pageof 1